Tests topical antibiotics’ anti-inflammatory effect in acne
Part of Skin clinical trials.
This trial studies whether putting antibiotic creams on mild-to-moderate facial acne reduces inflammation. It may help answer whether topical erythromycin or clindamycin can improve acne-related redness and swelling.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re age 18 to 45 and generally healthy with no serious uncontrolled ongoing diseases.
- You have mild-to-moderate inflammatory acne on your face for at least 6 months, with at least 5 inflammatory spots.
- You have no more than 5 nodules (deeper acne bumps) at the start of the study.
- You can’t use acne treatments on your skin right before enrollment: no topical anti-acne products in the last 2 weeks.
- No oral acne medicines that act on the whole body: no oral/systemic acne treatment or antibiotics in the last 4 weeks; no isotretinoin in the last 6 months.
- You must not be pregnant or breastfeeding, and you must be willing to avoid sun tanning/booths for 3 weeks and consent to small skin punch biopsies.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests three different gel treatments for mild to moderate acne on the face. One gel contains clindamycin and retinoid, another adds dexamethasone, and the third uses a special stem-cell secretion. All are applied to the face for 8 weeks.
This study tests whether balancing the bacteria on your skin can help treat mild to moderate acne. Researchers will take facial photos and follow your progress to see if this new approach works.
This study tests if metronidazole gel or clindamycin gel works better for people with moderate acne. It aims to find a good treatment option for you.
This trial tests a cream called KR230109 for mild to moderate facial acne. It aims to see if the cream is safe and works well. You may qualify if you are 18 to 40 and have at least 10 pimples and 20 blackheads or whiteheads on your face, but no deep cysts.
This trial tests if a new cleanser and cream combination can safely treat mild to moderate acne. It may help people who have not used other acne treatments recently.
This trial tests a new medicine, HB0043, to see if it helps adults with moderate to severe facial acne. You cannot use other acne treatments during the study.
Hear when a new Acne Vulgaris trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.